CD59 antibody
-
- Target See all CD59 Antibodies
- CD59
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This CD59 antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), ELISA, Immunofluorescence (IF)
- Specificity
- Binds to a 17-25kD glycoprotein which is distributed on human cells and has a glycosyl-phosphatidylinositol (GPI) linkage to the plasma membrane. Cell reactivity: Recognizes all leucocytes, platelets, fibroblasts, erythrocytes and most cell lines. It is negative on U937 and Daudi cell lines. It is reduced on affected cells from patients with PNH with a distribution reflecting the clonal nature of the disease.
- Purification
- Purified
- Immunogen
-
Human erythrocytes.
Type of Immunogen: Cells - Isotype
- IgG1
- Top Product
- Discover our top product CD59 Primary Antibody
-
-
- Application Notes
-
Approved: ELISA, Flo (1:25), IF (1:25)
Usage: Suitable for use in Flow Cytometry, Indirect Immunofluorescence, and ELISA. Flow Cytometry: 1:25. Indirect Immunofluorescence: 1:25. Dilute with isotonic buffer. Use 50 μL of the appropriate dilution per 1x1 x106 in 100 μL buffer. - Comment
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- 0.2 M PBS, pH 7.4, 0.2 % BSA, 0.1 % sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
-
Short term: -20°C
Long term: -20°C.
-
- Target
- CD59
- Alternative Name
- CD59 (CD59 Products)
- Background
-
Name/Gene ID: CD59
Synonyms: CD59, 16.3A5, 1F5, 1F5 antigen, CD59 glycoprotein, EL32, EJ16, G344, HRF-20, MAC-IP, MACIF, Ly-6-like protein, MEM43, MIRL, MEM43 antigen, MIN2, MIN3, MSK21, p18-20, Protectin, MAC-inhibitory protein, MIC11, T cell-activating protein, CD59 antigen, EJ30, HRF20, Human leukocyte antigen MIC11, Lymphocytic antigen CD59/MEM43, MIN1 - Gene ID
- 966
- UniProt
- P13987
- Pathways
- Complement System
-